Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial

Biology of Blood and Marrow Transplantation - Tập 18 - Trang 1859-1866 - 2012
Scott R. Solomon1, Connie A. Sizemore1, Melissa Sanacore1, Xu Zhang2, Stacey Brown1, H. Kent Holland1, Lawrence E. Morris1, Asad Bashey1
1Blood and Marrow Transplant Program at Northside Hospital, Atlanta Georgia
2Department of Mathematics and Statistics, Georgia State University, Atlanta, Georgia

Tài liệu tham khảo